The EPS projection of Aetna Inc. (NYSE:AET) for quarter ended 2016-09-30 is $2.05. Last week, the EPS forecast was $2.05 against target of $2.05, a month earlier. Two months ago, this estimate was $2.05 versus forecast of $2.05 three months earlier, implying a deviation of 0%.
Aetna Inc. (NYSE:AET) stated that 18 days ago, its stock price was positively revised 5 times while negative revisions were 2.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 7, 7, and 7, correspondingly.
EPS estimate downgrade for Aetna Inc. (NYSE:AET) in the preceding 30, 120, 60 and 90 days were 0, 3, 1, and 2, correspondingly.
Aetna Inc. (NYSE:AET) EPS target for the quarter closed 1 was $2.05, based on 12 recommendations. As reported on 2016-04-28 the EPS was $2.3. The change was $0.08, implying a percentage deviation of 3.6%. The projections showed a standard deviation of 0.13.
Quarterly Sales Estimates
Aetna Inc. (NYSE:AET) yearly sales prediction for the fiscal 2017 stands at $16736.872 and the median estimate is at $16934.12. Almost 5 analysts issued sales target.
Highest sales target is $17072.75 while the lowest target is $15794.4 showing standard deviation of 531.392%.
As many as 5 analysts have sales targets revised upside while 5 reduced sales estimates, implying a deviation of 0%.
Last month, 5 revised sales number projection on upside while 5 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 5 hiked sales target and 5 reduced sales forecast. Aetna Inc. (NYSE:AET) announced that the deviation in forecast was 0.513%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...